139 related articles for article (PubMed ID: 17954504)
1. Risk of antigen excess in serum free light chain measurements.
Daval S; Tridon A; Mazeron N; Ristori JM; Evrard B
Clin Chem; 2007 Nov; 53(11):1985-6. PubMed ID: 17954504
[No Abstract] [Full Text] [Related]
2. Biological variation of free light chains in serum.
Braga F; Infusino I; Dolci A; Panteghini M
Clin Chim Acta; 2013 Jan; 415():10-1. PubMed ID: 22981867
[No Abstract] [Full Text] [Related]
3. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
[TBL] [Abstract][Full Text] [Related]
5. Sharply increased serum free light-chain concentrations after treatment for multiple myeloma.
Murata K; Clark RJ; Lockington KS; Tostrud LJ; Greipp PR; Katzmann JA
Clin Chem; 2010 Jan; 56(1):16-8. PubMed ID: 20040623
[No Abstract] [Full Text] [Related]
6. Comparison of free κ and λ light chain immunoassays and total (bound and free) κ and λ light chain immunoassays.
Delgado F; Kuus K
Rev Invest Clin; 2014; 66(5):473-4. PubMed ID: 25695391
[No Abstract] [Full Text] [Related]
7. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.
Drayson M; Tang LX; Drew R; Mead GP; Carr-Smith H; Bradwell AR
Blood; 2001 May; 97(9):2900-2. PubMed ID: 11313287
[TBL] [Abstract][Full Text] [Related]
8. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
11. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
Levinson SS
Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
[TBL] [Abstract][Full Text] [Related]
12. Critical evaluation of the serum kappa/lambda light-chain ratio in the detection of M proteins.
Laine ST; Soppi ET; Mörsky PJ
Clin Chim Acta; 1992 Apr; 207(1-2):143-9. PubMed ID: 1591862
[No Abstract] [Full Text] [Related]
13. Polyclonal serum free light chains: a biomarker of disease prognosis or of immune senescence?
Bibas M
J Clin Oncol; 2012 Aug; 30(24):3033-4; author reply 3034. PubMed ID: 22778319
[No Abstract] [Full Text] [Related]
14. Immunochemical evaluation of monoclonal gammopathies: heavy chain to light chain ratio is of little practical value for detecting IgD myelomas and free light chains.
Bianchi P; MacNamara E; Bergami MR; Gasparro C; Jones R; Whicher JT; Bienvenu J; Aguzzi F
Clin Chem; 1992 Feb; 38(2):317-9. PubMed ID: 1541025
[No Abstract] [Full Text] [Related]
15. Automated alarm to detect antigen excess in serum free immunoglobulin light chain kappa and lambda assays.
Urdal P; Amundsen EK; Toska K; Klingenberg O
Scand J Clin Lab Invest; 2014 Oct; 74(7):575-81. PubMed ID: 25007050
[TBL] [Abstract][Full Text] [Related]
16. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
17. Analytical performance of the serum free light chain assay.
Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L
Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
19. Serum-free light chain analysis: works in progress.
Merlini G
Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
[No Abstract] [Full Text] [Related]
20. Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.
Bossuyt X; Delforge M; Reynders M; Dillaerts D; Sprangers B; Fostier K; Poesen K; Vercammen M
Leukemia; 2018 Aug; 32(8):1815-1818. PubMed ID: 29674643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
